Bentec GmbH, an operating entity of Kenera Energy Solutions, has entered into an agreement with UK-based green hydrogen technology company, CPH2 to produce CPH2’s membrane-free eectrolysers (MFE).
Kenera is a newly formed business unit within leading drilling, engineering and technology company KCA Deutag Group. Kenera has been formed as the platform from which the KCA Deutag Group shall grow its offering within hydrocarbon and energy transition markets and is a significant investor in CPH2.
Under the terms of the Agreement, Kenera will manufacture up to 30 MFE220 units for CPH2 at its manufacturing facility in Germany. In addition, CPH2 has granted Kenera a non-exclusive license to sell and manufacture CPH2 products in Germany, Scotland, Azerbaijan, Denmark and Norway up to a maximum of 150 MFE units per annum.
CPH2 has also granted Kenera an exclusive license to sell and manufacture CPH2 products across the Middle East up to a maximum level of 2GW (including Oman, Saudi Arabia, United Arab Emirates, Qatar, Kuwait and Iraq).
Jon Duffy, CEO of CPH2 said:
“We are delighted to enter into this agreement with Kenera, whose parent company, KCA Deutag, is not only an investor in CPH2, but is also one of the leading energy sector manufacturing businesses in the world, adding valuable and immediate manufacturing capacity.
“I am particularly pleased to have additionally signed two sales licensing sub-agreements, which are a capital efficient production method for CPH2, and will enable a much faster scale up and market penetration of our innovative and disruptive hydrogen electrolyser technology. Interest in this technology continues to grow and our pipeline of opportunities is constantly developing.”
Ally Hogg, Head of Commercial for Kenera, commented:
“This collaboration follows our investment into this exciting and ambitious high growth hydrogen business. The relationship with CPH2 adds to our clean energy portfolio and we look forward to actively collaborating with their team as we expand our business in the energy transition space and create value for our stakeholders by delivering our innovative technological solutions, manufacturing and after-sales expertise.”
The Agreement brings together CPH2’s innovative MFE technology, which uses cryogenics to separate oxygen from hydrogen, and Kenera’s international client base and industry-leading manufacturing capabilities.